ImmunogenX

ImmunogenX is a company developing a therapy for individuals with celiac disease. It also provides a diagnostic tool using a metabolic marker compound that measures the state of recovery of a celiac patient undergoing gluten-free diet treatment. Additionally, the company is engaged in research focused on gluten toxic peptide epitopes in wheat, barley, and rye.